Literature DB >> 20351676

A consensus conference on complex biologics and low molecular weight heparins.

E Kalodiki1, J Fareed, V F Tapson, D A Hoppensteadt, I Sussman, C A Carter, S Parker, J Harenberg, R Hull, G Rao, D F Lovinger, L D Ried, A Kakkar, L Talarico, F Ofuso, H I Bussey, J Fanikos, J B Groce, N Skinner, M Ahluwalia, O Iqbal, C M Jackson, W P Jeske, M Georges, E Ramacciotti, V F Tapson, D Van Thiel, R Wahi, J Walenga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20351676

Source DB:  PubMed          Journal:  Int Angiol        ISSN： 0392-9590            Impact factor:   2.789


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees.

Authors:  Alpesh Amin
Journal:  Pharmaceuticals (Basel)       Date:  2011-11-07

Review 2.  The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV).

Authors:  Davide Imberti; Marco Marietta; Hernan Polo Friz; Claudio Cimminiello
Journal:  Thromb J       Date:  2017-05-10

3.  Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.

Authors:  Eduardo Ramacciotti; Ariane Scarlatelli Macedo; Rodrigo Bruno Biagioni; Roberto Augusto Caffaro; Renato Delascio Lopes; João Carlos Guerra; Fernanda Andrade Orsi; Marcos Areas Marques; Alfonso J Tafur; Joseph A Caprini; Andrew Nicolaides; Charles A Carter; Cyrillo Carvalheiro Filho; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  Update on the safety and bioequivalence of biosimilars - focus on enoxaparin.

Authors:  Walter Jeske; Jeanine M Walenga; Debra Hoppensteadt; Jawed Fareed
Journal:  Drug Healthc Patient Saf       Date:  2013-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.